Skip to Main Content

Author Details

Christopher P Austin
St. George's University Medical School
1990
267
79
PMIDPaper TitleJournal TitlePublished Year
37007368Role of Plasmapheresis in Hemolysis, Elevated Liver Enzymes and Low Platelets (HELLP) Syndrome.Cureus2023
37456265A framework for assessing clinical trial site readiness.J Clin Transl Sci2023
35182735Defining clinical outcome pathways.Drug Discov Today2022
35774700Supraventricular Tachycardia: An Atypical Presentation of Thyroid Storm.Cureus2022
35832767Lemierre's Syndrome: A Comeback Story.Cureus2022
35754433Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences.J Clin Transl Sci2022
36134087Iodinated Contrast-Induced Thyroid Storm With Concomitant Cardiac Tamponade: A Case Report.Cureus2022
36253455The NCATS Assay Guidance Manual programme: advancing the practice and rigour of preclinical translation.Nat Rev Drug Discov2022
32968225The failure to fail smartly.Nat Rev Drug Discov2021
33623157Biological activity-based modeling identifies antiviral leads against SARS-CoV-2.Nat Biotechnol2021
34045734Envisioning an actionable research agenda to facilitate repurposing of off-patent drugs.Nat Rev Drug Discov2021
33941937A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells.Nat Methods2021
34239500Discovery Genome-Wide Association Study of Body Composition in 4,386 Adults From the UK Biobank's Pilot Imaging Enhancement Study.Front Endocrinol (Lausanne)2021
33982407Opportunities and challenges in translational science.Clin Transl Sci2021
34111271Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.J Infect Dis2021
34255046Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.JAMA Netw Open2021
34164155Foreword to the JCTS COVID-19 special issue.J Clin Transl Sci2021
33462425Translational misconceptions.Nat Rev Drug Discov2021
33140634The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology.Chem Res Toxicol2021
32805036The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.J Am Med Inform Assoc2021
32913334Organs-on-chips: into the next decade.Nat Rev Drug Discov2021
32993373The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.Hum Gene Ther2020
33501158Exploring Novel Biologically-Relevant Chemical Space Through Artificial Intelligence: The NCATS ASPIRE Program.Front Robot AI2020
31873296A call for global action for rare diseases in Africa.Nat Genet2020
31836861Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.Nat Rev Drug Discov2020
31913355Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.Nat Rev Drug Discov2020
33244424The CTSA program's role in improving rural public health: Community-engaged disease prevention and health care innovation.J Clin Transl Sci2020
32766591Massive-scale biological activity-based modeling identifies novel antiviral leads against SARS-CoV-2.bioRxiv2020
30700523The NIH Blueprint for Neuroscience Research Seeks Community Input on Future Neuroscience Investments.J Neurosci2019
32259057The Fundamental Characteristics of a Translational Scientist.ACS Pharmacol Transl Sci2019
31585169The NCATS Pharmaceutical Collection: a 10-year update.Drug Discov Today2019
31367046The FNIH Biomarkers Consortium embraces the BEST.Nat Rev Drug Discov2019
30710133Mapping biologically active chemical space to accelerate drug discovery.Nat Rev Drug Discov2019
30979709International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.EMBO Mol Med2019
31133849The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics.Front Pharmacol2019
30648736The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction.Clin Pharmacol Ther2019
30412342Deconstructing the Translational Tower of Babel.Clin Transl Sci2019
28796411Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.Clin Transl Sci2018
29930285Genome editing to 're-write' wrongs.Nat Rev Drug Discov2018
30250647Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.Oncotarget2018
29877628Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery.Clin Transl Sci2018
30059008Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic Studies.Environ Health Perspect2018
29870792Recommendations toward a human pathway-based approach to disease research.Drug Discov Today2018
31245596The Global academic research organization network: Data sharing to cure diseases and enable learning health systems.Learn Health Syst2018
30400963From scientific discovery to treatments for rare diseases - the view from the National Center for Advancing Translational Sciences - Office of Rare Diseases Research.Orphanet J Rare Dis2018
29674698Translating translation.Nat Rev Drug Discov2018
29491351Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles.Sci Rep2018
29271559Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.Clin Transl Sci2018
29269942A dynamic map for learning, communicating, navigating and improving therapeutic development.Nat Rev Drug Discov2018
29348682Glimmers in illuminating the druggable genome.Nat Rev Drug Discov2018
  • 1 - 50 of 267

Recommended Authors

Center for Drug Evaluations and Research (CDER)
Career Start Year 2013
Number of shared co-authors 2
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 2
Johns Hopkins School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 4
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 3
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Columbia University
Career Start Year 1998
Number of shared co-authors 6
university of massachusetts amherst Chan Medical School
Career Start Year 1998
Number of shared co-authors 8
Bowdoin College
Career Start Year 1997
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 2
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 0
University of New Mexico School of Medicine
Career Start Year 1995
Number of shared co-authors 13
Institute of Biomedical Sciences
Career Start Year 1995
Number of shared co-authors 0
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 1
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 9
Atux Iskay LLC
Career Start Year 1993
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 5
Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
Bill & Melinda Gates Foundation
Career Start Year 1990
Number of shared co-authors 4
Novartis
Career Start Year 1988
Number of shared co-authors 3
Vrije Universiteit Amsterdam (VU)
Career Start Year 1987
Number of shared co-authors 2
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 5
University of Michigan Medical School ann arbor
Career Start Year 1977
Number of shared co-authors 10
Exercise Medicine Research Institute, Edith Cowan University
Career Start Year 1973
Number of shared co-authors 2
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 4

Collaborators

National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 53
Co-authored papers 44
Co-authored papers 32
Center for Cancer Research, National Cancer Institute
Co-authored papers 25
National Institute of Environmental Health Sciences
Co-authored papers 23
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 14
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 11
Howard Hughes Medical Institute, Harvard Medical School
Co-authored papers 11
National Institute of Environmental Health Sciences/National Institutes of Health
Co-authored papers 10
Novartis Gene Therapies
Co-authored papers 7
Children's Hospital of Eastern Ontario
Co-authored papers 7
King Edward Memorial Hospital
Co-authored papers 6
The University of Notre Dame Australia
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Vertex Pharmaceuticals
Co-authored papers 6
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 5
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 5
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
McGill University. Montreal
Co-authored papers 4
INSERM
Co-authored papers 4
Co-authored papers 4
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 4
University of Michigan ann arbor
Co-authored papers 4
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 4
Co-authored papers 4
Kangwon National University College of Medicine
Co-authored papers 3